SOMERVILLE, Mass.--(BUSINESS WIRE)--bluebird bio, Inc. (NASDAQ: BLUE) (“bluebird”), Carlyle (NASDAQ: CG) (“Carlyle”) and SK Capital Partners, LP (“SK ...
The new $5-per-share offer can be viewed as a win for bluebird investors, as the original deal's CVR term seems unattainable. (designer491/iStock/Getty Images Plus ...
bluebird will focus on expanding manufacturing capacity and improving the treatment experience for patients and providers David Meek, who became Chief Executive Officer of bluebird at close, said, ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Investors in bluebird bio have agreed to a sale to Carlyle and SK Capital after weeks of refusing to tender their shares. (SOPA Images/LightRocket/Getty Images) With a better upfront offer on the ...
All conditions of the Offer have been satisfied and the parties expect to consummate the acquisition on June 2, 2025 WASHINGTON & NEW YORK--(BUSINESS WIRE)--Carlyle (NASDAQ: CG) (“Carlyle”), SK ...
Bluebird bio (NASDAQ:BLUE) jumped 50% in premarket trading after announcing an amended deal with Carlyle Group (CG) and SK Capital. Under the amended agreement, bluebird (NASDAQ:BLUE) holders can ...
bluebird bio, Inc. (NASDAQ: BLUE) (“bluebird”) today announced that it has entered into a definitive agreement to be acquired by funds managed by global investment firms Carlyle (NASDAQ: CG) and SK ...
(RTTNews) - Investment firm Carlyle Group Inc. (CG), along with SK Capital Partners, LP and Beacon Parent Holdings, L.P., on Friday announced that the proposed acquisition of bluebird bio, Inc. (BLUE) ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results